Jennifer Leavitt, MS

Five notable abstracts from the 2019 World Conference on Lung Cancer (WCLC).

Most recently, the FDA approved cabozantinib for the treatment of HCC, but this drug has a history. 

Here, we look at the currently open and recruiting clinical trials that focus on the role of the microbiome in colorectal cancer.

Our team reviews the most important advances in oncology in 2018, including those in breast cancer, hematologic cancers, lung cancer, immunotherapy, and more.

Our team reviews 2018 conference highlights in oncology care, including studies from ASH, SABCS, and SIO.

Introducing the new ONCOLOGY, with a new team and a new look.